Similar Articles |
|
Pharmaceutical Executive May 1, 2005 |
What Does It Take to be a Global Leader in Training An interview with Ed Yavuz, Wyeth's vice president of sales training and management development about the company's learning strategy, core curriculum for both reps and managers, and the relationship between training and retention of key employees. |
Pharmaceutical Executive February 1, 2012 Wilcox et al. |
Sales Force Survey: Still Too Much Business as Usual? In the global battle for market share, the ability to adapt and mobilize your human assets around a responsive commercial model is a key variable of success. |
Pharmaceutical Executive November 1, 2006 Barricklow & Bandy |
Meetings: Before and After Maximize sales meetings by focusing on strong pre- and post-meeting initiatives. |
Pharmaceutical Executive February 1, 2006 Nappi & Rodgers |
Marketing to Professionals: Streamlined Scheduling Better scheduling of sales visits can increase doctors' receptivity to pharmaceutical reps. |
Pharmaceutical Executive May 1, 2005 Manson & Katzenberg |
Unleash the Tablets In their rush to get tablet PCs into reps' hands, pharma companies can't forget one crucial step--training. |
Pharmaceutical Executive October 1, 2006 Scott Hull |
Back to the Future? Some states want to block access to doctor-level prescribing data. And the AMA helps members keep prescription records away from sales reps. An "old timer" remembers how he sold before databases came along. |
Pharmaceutical Executive March 1, 2009 Brittany Agro |
The New Sales Force The arms race is over, and it's time to reinvent pharma sales. Here's what forward-looking companies are experimenting with, and how it's working. |
Pharmaceutical Executive January 1, 2013 Torsten Bernewitz |
The Force Behind Sales Forces Don't underestimate the importance of the first line manager. |
Pharmaceutical Executive June 1, 2007 Breitstein & Armstrong |
Fixing the Sales Model Pharma's new commercialization strategy is, uh, in the works. But what did you expect? Getting it right takes time. |
Pharmaceutical Executive May 1, 2005 Sibyl Shalo |
Out to Lunch? For the average pharma rep, a 13-minute sales oriented meal trumps a 60-second office visit, any day of the week. |
Pharmaceutical Executive October 1, 2005 Christopher Lisanti |
Physician Frustration Doctors have had enough. But reps can still redeem themselves. As the industry thinks about new sales force models, it should look beyond ROI numbers, toward a new paradigm that not only works for pharma, but also for its customers. |
Pharmaceutical Executive May 1, 2005 Rosenthal & Herman |
Nobody Does it Better Keeping district managers in the field is just one way to keep your sales force productive. |
CRM November 2009 Lauren McKay |
Pharmaceuticals -- CRM Undergoes an Experimental New Treatment An older CRM vertical gets a new dose of on-demand technology. |
Pharmaceutical Executive May 1, 2005 Steven Tarnoff |
How to Keep Out of Regulatory Quicksand Pharma sales teams may soon need law degrees just to keep up with the changes in federal and state mandates. |
Pharmaceutical Executive October 1, 2005 Mike Iafolla & Steve Greco |
Under the Influence The number of influences that affect physicians' prescribing has increased and rep saturation has reached the tipping point, resulting in "customer fatigue." Companies must now take into account a plethora of influences when planning their sales and marketing efforts. |
Pharmaceutical Executive January 1, 2007 Davenport et al. |
Sales Slip Even before Pfizer blinked, companies were asking, "What ails sales?" In this annual survey, 50-plus pharmas and biotechs answer the hard questions about reps' productivity, profitability, and what to do about it. |
Pharmaceutical Executive May 1, 2012 |
The Personal Touch in Digital Promotion The shift from sales rep meetings to digital selling methods must include innovation and a physician-centered mindset in order to be successful. |
Pharmaceutical Executive May 1, 2006 Musacchio & Hunkler |
More Than a Game of Keep Away The Prescribing Data Restriction Program takes effect in July. The AMA explains how individual doctors can keep their prescribing habits safe from reps, and how pharma can keep using the anonymous data -- if the industry polices itself. |
Pharmaceutical Executive February 1, 2011 Scott Moldenhauer |
Accelerated Evolution Adapting training techniques for pharmaceutical sales representatives is necessary to thrive in the fact-changing dynamic of a physician's office |
Pharmaceutical Executive October 1, 2010 |
Digital Alternatives Define New Sales Force Today's pharmaceutical sales teams must adapt techniques to embrace new technologies in order to remain successful. |
Pharmaceutical Executive September 1, 2005 Nickum & Kelly |
Missing the Mark(et) Pharmaceutical companies spend billions on data. Sales reps crowd the waiting rooms. So why is the doctor out? |
Pharmaceutical Executive February 1, 2011 Stan Bernard |
Are You Trained to Compete and Win? With the impact of the sales rep in decline, it's time to beef up training for other pharma functions to fill the gap in a competitive marketplace |
Pharmaceutical Executive August 1, 2005 |
Backpage: Feet-on-the-Street Interview A new survey asked pharmaceutical reps how their job has been changing. One bit of good news: A few reps think it's easier to get past the receptionist's desk. |
Pharmaceutical Executive May 1, 2011 Robert Neumann |
iDeal Tool of Sales Trade The sleek, portable iPad, coupled with customized apps, gives sales reps a leg up. |
Pharmaceutical Executive January 1, 2007 Jeffrey Zornitsky |
Sales Management: Get Committed By better managing relationships with physicians, pharma companies can develop a base of dedicated prescribers. |
Pharmaceutical Executive January 1, 2009 Carrie Fisher |
Uneven Landscape The headlines are about layoffs, but some segments of pharma are still hiring. Pay, meanwhile, tightens. |
Pharmaceutical Executive June 1, 2006 Cindy D'Aoust |
Who's Coming to Meetings? Need to attract the "right" physicians to a promotional meeting? Have to do it on a budget while following new compliance rules? Check out this new survey to see how the rest of pharma lives with a shifting promotional landscape. |
Pharmaceutical Executive June 1, 2005 Patrick Burns |
Sales Management: A Sample Plan One of the pharma industry's most important promotional tools is also one of its least understood. Here are new approaches to measuring the impact of sampling--and giving reps the tools they need to use samples better. |
Pharmaceutical Executive March 1, 2006 Sharyn Lee |
Invisible Prescribers: What You Do and Don't Know About NPs and PAs How many prescriptions are written each year by nurse practitioners and physician assistants? Pharmaceutical companies not only fail to market to this sector, they neglect to invite nurse practitioners and physician assistants to meetings or to include them in plans for continuing medical education. |
Pharmaceutical Executive April 1, 2006 David Duplay |
Marketing to Professionals: A Sample Plan Sure, pharmaceutical e-sampling can save money. But there are plenty of other reasons to use it. |
Pharmaceutical Executive January 1, 2006 Davenport & Fisher |
Sales Force Survey Base pay is up and incentives are easier to earn as the pharmaceuticals industry tries to hang onto top performers and attract new talent. |
CRM August 1, 2009 Lauren McKay |
The New Prescription for Pharma To address trends in the industry, pharmaceutical companies must do more with less and reshape their messages - not the easiest of tasks. |
Pharmaceutical Executive June 1, 2005 Zimmerman & Fay |
Marketing to Professionals: Dr. Ambassador The pharma industry is under siege in the news media. Smart companies must create a role for physicians as ambassadors who can raise patient confidence in drugs and the pharma industry as a whole. |
The Motley Fool September 15, 2011 Frank Vinluan |
GSK's New Drug Marketing Model: Pharma Reps As Educators, Not Sellers The conversation between sales reps and doctors today is vastly different compared to one year ago. |
BusinessWeek February 5, 2007 |
The Doctor Won't See You Now A host of forces is now converging to clamp down on hard-driving, gift-toting pharmaceutical pitchmasters who have been ambushing physicians for the last decade. |
Pharmaceutical Executive March 1, 2006 Jeff Brady |
Sales Management: Spending Under Scrutiny Five states have already mandated that drug companies track, control, and report their marketing and sales spend directed at healthcare professionals, and many more states have legislation pending with distinct requirements. |
Pharmaceutical Executive April 1, 2007 |
Sales Management: The New BioPharma Representative With today's sales force in flux, pharma is looking to a new sales elite. |
Pharmaceutical Executive July 30, 2007 Stewart Young |
Marketing to Professionals: The Essence of a Brand Beyond good messaging, marketers must establish a brand that is forever etched into physicians' minds. |
Pharmaceutical Executive November 1, 2014 |
Sales Reps and the New Commercial Organization By rethinking the role of the sales rep and the new skills it demands, pharma companies can put themselves in a prime competitive position. |
Pharmaceutical Executive June 1, 2007 Michael Goodman |
A Very Specialty Moment Big Pharma is on a shopping spree for biologics and other specialty products. It has the money to buy them. But does it have the mojo to develop and market them successfully - or will the mid-size biopharmas make their big move? |
Pharmaceutical Executive November 1, 2008 Tousi & Lee |
Making Sense of Sales The direct sales force is one of the largest costs for most pharma companies, but don't throw out sales force effectiveness with the sales force when cutting costs. Read on for some sure-fire strategies. |
Pharmaceutical Executive September 1, 2006 |
Sewing Up New Sales Simple, elegant lines are the backbone of any good design, including a new sales model. Get that right, and your model can be tailored to fit any customer. |
Pharmaceutical Executive August 1, 2008 William Schiemann |
Do Something! Seven steps you never knew that could fix the sales force. |
Pharmaceutical Executive January 1, 2012 |
Compliance: Getting Those Ducks in a Row Pharma must coordinate the efforts of medical, legal, HR, global partners and many other players in the regulatory compliance space to keep itself afloat in choppy seas. |
Pharmaceutical Executive January 1, 2011 |
The San Diego Story San DIego works as a locus for risky investments in the big ideas that lead to biotech breakthroughs |
Pharmaceutical Executive September 1, 2005 Ray Altieri |
Return on Opportunity Conventions synergize all communications vehicles and create a total impact on the market: advertising, Web presence, programs, detailing, and non-prescription sampling. |
Pharmaceutical Executive June 1, 2005 Boschwitz et al. |
Track Patients, Not Prescriptions Why pharma companies reject anonymous patient-level data, and why they can't do without it for long. |
Pharmaceutical Executive May 1, 2009 |
Why All the Bad Buzz? European docs have always been down on pharma - but now the US is catching on. Perhaps pharma has oversold the "service model." |
Pharmaceutical Executive April 1, 2007 Walter Armstrong |
Make It New To fix pharma's business model, nothing less than big, bold, and risky fits the bill. Two radical new visions focus on getting back to the roots of innovation -- and letting a thousand flowers bloom. |
Pharmaceutical Executive January 1, 2007 Sander Flaum |
Leadership: If Bill Gates Ran PhRMA Pharma has a classic image problem. Sometimes the products don't do what they're supposed to. Innovation is key, but too slow. Business practices can look sleazy. What if our spokesman was a guy who'd beaten those problems? |